公告 Notification filed by national security exchange to report the removal from lis

发表于 2023-01-03 23:06   271次浏览

公告 Securities to be offered to employees in employee benefit plans, post-effective

发表于 2023-01-03 22:38   200次浏览

公告 [Amend] Solicitation, recommendation statements

发表于 2023-01-03 22:32   207次浏览

公告 [Amend] Tender offer statement by Third Party

发表于 2023-01-03 22:32   220次浏览

公告 Current report, items 1.02, 2.01, 3.01, 3.03, 5.01, 5.02, 5.03, and 9.01

发表于 2023-01-03 22:32   202次浏览

公告 Securities to be offered to employees in employee benefit plans, post-effective

发表于 2023-01-03 22:31   209次浏览

公告 Securities to be offered to employees in employee benefit plans, post-effective

发表于 2023-01-03 22:31   215次浏览

公告 Post-Effective amendments for registration statement

发表于 2023-01-03 22:31   216次浏览

公告 Securities to be offered to employees in employee benefit plans, post-effective

发表于 2023-01-03 22:29   222次浏览

公告 Oyster Point Pharma Inc|Contract Adjustment

发表于 2023-01-03 00:00   94次浏览

公告 [Amend] Solicitation, recommendation statements

发表于 2022-12-23 19:50   353次浏览

公告 Solicitation, recommendation statements

发表于 2022-12-23 06:56   245次浏览

公告 [Amend] General statement of acquisition of beneficial ownership

发表于 2022-12-21 19:29   253次浏览

公告 [Amend] Solicitation, recommendation statements

发表于 2022-12-09 20:09   239次浏览

公告 [Amend] Tender offer statement by Third Party

发表于 2022-12-09 20:09   213次浏览

公告 [Amend] Statement of changes in beneficial ownership of securities

发表于 2022-12-07 10:10   229次浏览

公告 Oyster Point Pharma Inc|4：持股变动声明

发表于 2022-12-06 22:21   234次浏览

公告 Statement of changes in beneficial ownership of securities

发表于 2022-12-06 08:20   234次浏览

公告 Solicitation, recommendation statements

发表于 2022-12-01 20:46   209次浏览

公告 Tender offer statement by Third Party

发表于 2022-12-01 19:22   197次浏览